Volume 387, Issue 10023, Pages (March 2016)

Slides:



Advertisements
Similar presentations
Volume 12, Issue 9, Pages (September 2011)
Advertisements

Volume 376, Issue 9747, Pages (October 2010)
Volume 386, Issue 9992, Pages (August 2015)
Volume 378, Issue 9809, Pages (December 2011)
Volume 388, Issue 10042, Pages (July 2016)
Volume 17, Issue 2, Pages (February 2016)
Volume 14, Issue 10, Pages (September 2013)
Volume 372, Issue 9633, Pages (July 2008)
Volume 385, Issue 9972, Pages (March 2015)
Volume 17, Issue 2, Pages (February 2016)
Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised.
Volume 383, Issue 9919, Pages (March 2014)
Volume 377, Issue 9783, Pages (June 2011)
Volume 384, Issue 9952, Pages (October 2014)
Volume 373, Issue 9666, Pages (March 2009)
Volume 16, Issue 13, Pages (October 2015)
Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation.
Volume 15, Issue 10, Pages (September 2014)
Volume 372, Issue 9633, Pages (July 2008)
Volume 16, Issue 8, Pages (August 2015)
Volume 387, Issue 10024, Pages (March 2016)
Volume 15, Issue 8, Pages (July 2014)
Volume 15, Issue 2, Pages (February 2014)
Volume 14, Issue 4, Pages (April 2015)
Volume 374, Issue 9707, Pages (December 2009)
Volume 383, Issue 9919, Pages (March 2014)
Volume 373, Issue 9663, Pages (February 2009)
Volume 2, Issue 11, Pages (November 2015)
Volume 15, Issue 4, Pages (April 2014)
Montelukast for postinfectious cough in adults: a double-blind randomised placebo- controlled trial  Dr Kay Wang, DPhil, Surinder S Birring, MD, Kathryn.
Volume 12, Issue 7, Pages (July 2011)
Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP.
Volume 386, Issue 9998, Pages (September 2015)
Volume 15, Issue 6, Pages (May 2014)
Volume 15, Issue 1, Pages (January 2014)
Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label,
Volume 387, Issue 10022, Pages (March 2016)
Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.
Volume 383, Issue 9918, Pages (February 2014)
Volume 386, Issue 9992, Pages (August 2015)
Volume 20, Issue 1, Pages (January 2019)
Volume 18, Issue 3, Pages (March 2017)
Volume 15, Issue 10, Pages (September 2014)
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled,
Volume 19, Issue 4, Pages (April 2018)
Volume 15, Issue 8, Pages (July 2014)
Volume 371, Issue 9625, Pages (May 2008)
Volume 388, Issue 10042, Pages (July 2016)
Volume 16, Issue 15, Pages (November 2015)
Volume 383, Issue 9922, Pages (March 2014)
Volume 15, Issue 6, Pages (May 2014)
Volume 13, Issue 11, Pages (November 2012)
Volume 3, Issue 1, Pages (January 2016)
Volume 16, Issue 15, Pages (November 2015)
Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: a randomised double-blind, placebo-controlled trial  Dr.
Volume 5, Issue 4, Pages (April 2018)
Volume 16, Issue 8, Pages (August 2015)
Volume 378, Issue 9809, Pages (December 2011)
Volume 17, Issue 2, Pages (February 2016)
Volume 152, Issue 1, Pages (January 2019)
Volume 15, Issue 1, Pages (January 2014)
Volume 387, Issue 10022, Pages (March 2016)
Volume 12, Issue 8, Pages (August 2013)
Volume 375, Issue 9715, Pages (February 2010)
Volume 376, Issue 9747, Pages (October 2010)
Volume 13, Issue 5, Pages (May 2012)
Volume 372, Issue 9632, Pages (July 2008)
Volume 2, Issue 4, Pages (April 2015)
Volume 20, Issue 7, Pages (July 2019)
Volume 17, Issue 2, Pages (February 2016)
Presentation transcript:

Volume 387, Issue 10023, Pages 1066-1074 (March 2016) Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial  Prof Jonathan A Ledermann, MD, Andrew C Embleton, MSc, Fharat Raja, BMBCh, Prof Timothy J Perren, MD, Prof Gordon C Jayson, PhD, Prof Gordon J S Rustin, MD, Prof Stan B Kaye, MD, Hal Hirte, MD, Prof Elizabeth Eisenhauer, MD, Michelle Vaughan, MB, Prof Michael Friedlander, MD, Antonio González-Martín, MD, Daniel Stark, MD, Elizabeth Clark, BSc, Laura Farrelly, MSc, Prof Ann Marie Swart, MB, Adrian Cook, MSc, Prof Richard S Kaplan, MD, Prof Mahesh K B Parmar, DPhil  The Lancet  Volume 387, Issue 10023, Pages 1066-1074 (March 2016) DOI: 10.1016/S0140-6736(15)01167-8 Copyright © 2016 Ledermann et al. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 1 Trial profile SAE=serious adverse events. ITT=intention to treat. ECOG=Eastern Cooperative Oncology Group. The Lancet 2016 387, 1066-1074DOI: (10.1016/S0140-6736(15)01167-8) Copyright © 2016 Ledermann et al. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 2 Kaplan-Meier plot of progression-free survival over 2 years Vertical reference line shows the median time to completion of the chemotherapy phase. Number at risk every 6 months shown with the number of failure events in parentheses, after the time in which the number at risk was calculated. The Lancet 2016 387, 1066-1074DOI: (10.1016/S0140-6736(15)01167-8) Copyright © 2016 Ledermann et al. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 3 Kaplan-Meier plot of overall survival over 3 years Number at risk every 12 months shown with the number of failure events in parentheses, after the time in which the number at risk was calculated. The Lancet 2016 387, 1066-1074DOI: (10.1016/S0140-6736(15)01167-8) Copyright © 2016 Ledermann et al. Open Access article distributed under the terms of CC BY Terms and Conditions